The FDA’s Center for Biologics Evaluation and Research (CBER) cited Moderna’s choice of a licensed standard-dose flu vaccine as the comparator in its Phase 3 trial, saying it “does not reflect the best-available standard of care.”
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year
The new service delivers end-to-end support, managing every stage of an epigenomics project
Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%
The Phase III programme, Enith1 and Enith2, is expected to launch this quarter
Gastrointestinal conditions affect millions across the UK, yet research in the field has often been fragmented, slow, or under-resourced
Treatment typically requires frequent injections directly into the eye—an ongoing burden for patients and health systems alike
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
